[1] A. Huber, F. Menconi, S. Corathers, E.M. Jacobson, Y. Tomer, Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: From epidemiology to mechanisms, Endocr. Rev. 29 (2008) 697–725. doi:10.1210/er.2008-0015.
[2] D. Nabriski, M. Ellis, R. Ness-Abramof, M. Shapiro, L. Shenkman, Autoimmune thyroid disease and antiphospholipid antibodies, Am. J. Hematol. 64 (2000) 73–75. doi:10.1002/(SICI)1096-8652(200005)64:1<73::AID-AJH14>3.0.CO;2-U.
[3] H.J. Lee, C.W. Li, S.S. Hammerstad, M. Stefan, Y. Tomer, Immunogenetics of autoimmune thyroid diseases: A comprehensive review, J. Autoimmun. 64 (2015) 82–90. doi:10.1016/j.jaut.2015.07.009.
[4] X. Chu, C.M. Pan, S.X. Zhao, J. Liang, G.Q. Gao, X.M. Zhang, G.Y. Yuan, C.G. Li, L.Q. Xue, M. Shen, W. Liu, F. Xie, S.Y. Yang, H.F. Wang, J.Y. Shi, W.W. Sun, W.H. Du, C.L. Zuo, J.X. Shi, B.L. Liu, C.C. Guo, M. Zhan, Z.H. Gu, X.N. Zhang, F. Sun, Z.Q. Wang, Z.Y. Song, C.Y. Zou, W.H. Sun, T. Guo, H.M. Cao, J.H. Ma, B. Han, P. Li, H. Jiang, Q.H. Huang, L. Liang, L. Bin Liu, G. Chen, Q. Su, Y. De Peng, J.J. Zhao, G. Ning, Z. Chen, J.L. Chen, S.J. Chen, W. Huang, H.D. Song, A genome-wide association study identifies two new risk loci for Graves’ disease, Nat. Genet. 43 (2011) 897–901. doi:10.1038/ng.898.
[5] B.M. Dechairo, D. Zabaneh, J. Collins, O. Brand, G.J. Dawson, A.P. Green, I. Mackay, J.A. Franklyn, J.M. Connell, J.A.H. Wass, W.M. Wiersinga, L. Hegedus, T. Brix, B.G. Robinson, P.J. Hunt, A.P. Weetman, A.H. Carey, S.C. Gough, Association of the TSHR gene with Graves’ disease: The first disease specific locus, Eur. J. Hum. Genet. 13 (2005) 1223–1230. doi:10.1038/sj.ejhg.5201485.
[6] M. Maierhaba, J.A. Zhang, Z.Y. Yu, Y. Wang, W.X. Xiao, Y. Quan, B.N. Dong, Association of the thyroglobulin gene polymorphism with autoimmune thyroid disease in Chinese population, Endocrine. 33 (2008) 294–299. doi:10.1007/s12020-008-9082-x.
[7] Y. Ban, T. Tozaki, T. Tobe, Y. Ban, E.M. Jacobson, E.S. Concepcion, Y. Tomer, The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: An association analysis in Caucasian and Japanese cohorts, J. Autoimmun. 28 (2007) 201–207. doi:10.1016/j.jaut.2007.02.016.
[8] D.A. Chistiakov, E.I. Chistiakova, N. V. Voronova, R.I. Turakulov, K. V. Savost’anov, A Variant of the Il2ra/Cd25 Gene Predisposing to Graves’ Disease is Associated with Increased Levels of Soluble Interleukin-2 Receptor, Scand. J. Immunol. 74 (2011) 496–501. doi:10.1111/j.1365-3083.2011.02608.x.
[9] M.E. Munroe, Functional roles for T cell CD40 in infection and autoimmune disease: The role of CD40 in lymphocyte homeostasis, Semin. Immunol. 21 (2009) 283–288. doi:10.1016/j.smim.2009.05.008.
[10] W.A. Teft, M.G. Kirchhof, J. Madrenas, a Molecular Perspective of Ctla-4 Function, Annu. Rev. Immunol. 24 (2006) 65–97. doi:10.1146/annurev.immunol.24.021605.090535.
[11] E.M. Jacobson, A. Huber, Y. Tomer, The HLA gene complex in thyroid autoimmunity: From epidemiology to etiology, J. Autoimmun. 30 (2008) 58–62. doi:10.1016/j.jaut.2007.11.010.
[12] N. Yan, Y.L. Yu, J. Yang, Q. Qin, Y.F. Zhu, X. Wang, R.H. Song, J.A. Zhang, Association of interleukin-17A and -17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases, Autoimmunity. 45 (2012) 533–539. doi:10.3109/08916934.2012.702814.
[13] H. Sun, Y. Xia, L. Wang, Y. Wang, X. Chang, PSORS1C1 may be involved in rheumatoid arthritis, Immunol. Lett. 153 (2013) 9–14. doi:10.1016/j.imlet.2013.06.001.
[14] A. Clop, A. Bertoni, S.L. Spain, M.A. Simpson, V. Pullabhatla, R. Tonda, C. Hundhausen, P. Di Meglio, P. De Jong, A.C. Hayday, F.O. Nestle, J.N. Barker, R.J.A. Bell, F. Capon, R.C. Trembath, An in-depth characterization of the major psoriasis susceptibility locus identifies candidate susceptibility alleles within an HLA-C enhancer element., PLoS One. 8 (2013) 1–8. doi:10.1371/journal.pone.0071690.
[15] H. Sun, B. Xu, Q. Meng, Q. Yang, X. Chang, PSORS1C1/CDSN is associated with ankylosing spondylitis, Jt. Bone Spine. 81 (2014) 268–272. doi:10.1016/j.jbspin.2013.10.003.
[16] C. Ciccacci, C. Perricone, F. Ceccarelli, S. Rufini, D. Di Fusco, C. Alessandri, F.R. Spinelli, E. Cipriano, G. Novelli, G. Valesini, P. Borgiani, F. Conti, A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene, PLoS One. 9 (2014) 2–8. doi:10.1371/journal.pone.0111991.
[17] T. Hughes, P. Coit, A. Adler, V. Yilmaz, K. Aksu, N. Düzgün, G. Keser, A. Cefle, A. Yazici, A. Ergen, E. Alpsoy, C. Salvarani, B. Casali, I. Kötter, J. Gutierrez-Achury, C. Wijmenga, H. Direskeneli, G. Saruhan-Direskeneli, A.H. Sawalha, Identification of multiple independent susceptibility loci in the HLA region in Behçet’s disease, Nat. Genet. 45 (2013) 319–324. doi:10.1038/ng.2551.
[18] S.J. Holm, L.M. Carlén, L. Mallbris, M. Ståhle-Bäckdahl, K.P. O’Brien, Polymorphisms in the SEEK1 and SPR1 genes on 6p21.3 associate with psoriasis in the Swedish population, Exp. Dermatol. 12 (2003) 435–444. doi:10.1034/j.1600-0625.2003.00048.x.
[19] Z. Xie, V. Nagarajan, D.E. Sturdevant, S. Iwaki, E. Chan, L. Wisch, M. Young, C.M. Nelson, S.F. Porcella, K.M. Druey, Genome-wide SNP analysis of the Systemic Capillary Leak Syndrome (Clarkson disease), Rare Dis. (Austin, Tex.). 1 (2013) 1–10. doi:10.4161/rdis.27445.
[20] L. Bossini-Castillo, J.E. Martin, J. Broen, C.P. Simeon, L. Beretta, O.Y. Gorlova, M.C. Vonk, N. Ortego-Centeno, G. Espinosa, P. Carreira, P.G. De La Peña, N. Oreiro, J.A. Román-Ivorra, M.J. Castillo, M.A. González-Gay, L. Sáez-Comet, I. Castellví, A.J. Schuerwegh, A.E. Voskuyl, A.M. Hoffmann-Vold, R. Hesselstrand, A. Nordin, C. Lunardi, R. Scorza, J.M. Van Laar, P.G. Shiels, A. Herrick, J. Worthington, C. Fonseca, C. Denton, F.K. Tan, F.C. Arnett, S. Assassi, B.P. Koeleman, M.D. Mayes, T.R.D.J. Radstake, J. Martin, Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study, Ann. Rheum. Dis. 72 (2013) 602–607. doi:10.1136/annrheumdis-2012-201888.
[21] R.C. Trembath, R.L. Clough, J.L. Rosbotham, A.B. Jones, R.D.R. Camp, A. Frodsham, J. Browne, R. Barber, J. Terwilliger, G.M. Lathrop, J.N.W.N. Barker, Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis, Hum. Mol. Genet. 6 (1997) 813–820. doi:10.1093/hmg/6.5.813.
[22] C.D. Veal, F. Capon, M.H. Allen, E.K. Heath, J.C. Evans, A. Jones, S. Patel, D. Burden, D. Tillman, J.N.W.N. Barker, R.C. Trembath, Family-Based Analysis Using a Dense Single-Nucleotide Polymorphism–Based Map Defines Genetic Variation at PSORS1, the Major Psoriasis-Susceptibility Locus, Am. J. Hum. Genet. 71 (2002) 554–564. doi:10.1086/342289.
[23] R.P. Nair, P.E. Stuart, I. Nistor, R. Hiremagalore, N.V.C. Chia, S. Jenisch, M. Weichenthal, G.R. Abecasis, H.W. Lim, E. Christophers, J.J. Voorhees, J.T. Elder, Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene., Am. J. …. 78 (2006) 827–51. doi:10.1086/503821.
[24] A. SGenetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2,Strange Amy,Capon Francesca et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.[J] .Nat. Genet., 2010, 42: 985-90.{A, 2010 #32}
[25] L.C. Tsoi, S.L. Spain, J. Knight, E. Ellinghaus, P.E. Stuart, F. Capon, J. Ding, Y. Li, T. Tejasvi, J.E. Gudjonsson, H.M. Kang, M.H. Allen, R. McManus, G. Novelli, L. Samuelsson, J. Schalkwijk, M. Ståhle, A.D. Burden, C.H. Smith, M.J. Cork, X. Estivill, A.M. Bowcock, G.G. Krueger, W. Weger, J. Worthington, R. Tazi-Ahnini, F.O. Nestle, A. Hayday, P. Hoffmann, J. Winkelmann, C. Wijmenga, C. Langford, S. Edkins, R. Andrews, H. Blackburn, A. Strange, G. Band, R.D. Pearson, D. Vukcevic, C.C.A. Spencer, P. Deloukas, U. Mrowietz, S. Schreiber, S. Weidinger, S. Koks, K. Kingo, T. Esko, A. Metspalu, H.W. Lim, J.J. Voorhees, M. Weichenthal, H.E. Wichmann, V. Chandran, C.F. Rosen, P. Rahman, D.D. Gladman, C.E.M. Griffiths, A. Reis, J. Kere, R.P. Nnair, A. Franke, J.N. Barker, G.R. Abecasis, J.T. Eelder, R. Ttrembath, K.C. Duffin, C. Helms, D. Goldgar, Y. Li, J. Paschall, M.J. Malloy, C.R. Pullinger, J.P. Kane, J. Gardner, A. Perlmutter, A. Miner, B.J. Feng, R. Hiremagalore, R.W. Ike, E. Christophers, T. Henseler, A. Ruether, S.J. Schrodi, S. Prahalad, S.L. Guthery, J. Fischer, W. Liao, P. Kwok, A. Menter, G.M. Lathrop, C. Wise, A.B. Begovich, A. Onoufriadis, M.E. Weale, A. Hofer, W. Salmhofer, P. Wolf, K. Kainu, U. Saarialho-Kere, S. Suomela, P. Badorf, U. Hüffmeier, W. Kurrat, W. Küster, J. Lascorz, R. Mössner, F. Schürmeier-Horst, M. Ständer, H. Traupe, J.G.M. Bergboer, M. Den Heijer, P.C. Van De Kerkhof, P.L.J.M. Zeeuwen, L. Barnes, L.E. Campbell, C. Cusack, C. Coleman, J. Conroy, S. Ennis, O. Fitzgerald, P. Gallagher, A.D. Irvine, B. Kirby, T. Markham, W.H.I. McLean, J. McPartlin, S.F. Rogers, A.W. Ryan, A. Zawirska, E. Giardina, T. Lepre, C. Perricone, G. Martín-Ezquerra, R.M. Pujol, E. Riveira-Munoz, A. Inerot, Å.T. Naluai, L. Mallbris, K. Wolk, J. Leman, A. Barton, R.B. Warren, H.S. Young, I. Ricano-Ponce, G. Trynka, F.J. Pellett, A. Henschel, M. Aurand, B. Bebo, C. Gieger, T. Illig, S. Moebus, K.H. Jöckel, R. Erbel, P. Donnelly, L. Peltonen, J.M. Blackwell, E. Bramon, M.A. Brown, J.P. Casas, A. Corvin, N. Craddock, A. Duncanson, J. Jankowski, H.S. Markus, C.G. Mathew, M.I. McCarthy, C.N.A. Palmer, R. Plomin, A. Rautanen, S.J. Sawcer, N. Samani, A.C. Viswanathan, N.W. Wood, C. Bellenguez, C. Freeman, G. Hellenthal, E. Giannoulatou, M. Pirinen, Z. Su, S.E. Hunt, R. Gwilliam, S.J. Bumpstead, S. Dronov, M. Gillman, E. Gray, N. Hammond, A. Jayakumar, O.T. McCann, J. Liddle, M.L. Perez, S.C. Potter, R. Ravindrarajah, M. Ricketts, M. Waller, P. Weston, S. Widaa, P. Whittaker, R.P. Neir, J.N.W.N. Barker, G.R. Abecasis, J.T. Elder, R.C. Trembath, Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity, Nat. Genet. 44 (2012) 1341–1348. doi:10.1038/ng.2467.
[26] A. Di Cesare, P. Di Meglio, F.O. Nestle, The IL-23Th17 axis in the immunopathogenesis of psoriasis, J. Invest. Dermatol. 129 (2009) 1339–1350. doi:10.1038/jid.2009.59.
[27] N. Figueroa-Vega, M. Alfonso-Pérez, I. Benedicto, F. Sánchez-Madrid, R. González-Amaro, M. Marazuela, Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto’s thyroiditis, J. Clin. Endocrinol. Metab. 95 (2010) 953–962. doi:10.1210/jc.2009-1719.
[28] T. Nathan, J.D. Lambert, Depression of the fast IPSP underlies paired-pulse facilitation in area CA1 of the rat hippocampus., J. Neurophysiol. 66 (1991) 1704–1715. doi:10.1152/jn.1991.66.5.1704.
[29] A. Kotkowska, E. Sewerynek, D. Domańska, D. Pastuszak-Lewandoska, E. Brzeziańska, Single nucleotide polymorphisms in the STAT3 gene influence AITD susceptibility, thyroid autoantibody levels, and IL6 and IL17 secretion, Cell. Mol. Biol. Lett. 20 (2015) 88–101. doi:10.1515/cmble-2015-0004.